Patient P-02685
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
24%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S16
- Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 22 DT-01 recommended — Dosing / Timing Recommendation DT-01
- Day 23 Patient accepted — Started DT-01 in the companion
- Day 28 GI symptom burden −18% vs expected — Dosing / Timing Recommendation DT-01
- Day 34 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 13.
Primary contributors, last 14 days
- GI instability+5
- Treatment adherence-4
- Inflammatory activity+3
- Toxicity-2
What helped?
- Dosing / Timing Recommendation DT-01Day 22Result: symptom burden −18%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable90 min
stable · +1.7 vs previous 14 d
Sleep duration
Wearable7.9 h
stable · -0.3 vs previous 14 d
Energy level
Daily log5.8/10
worsening · -0.3 vs previous 14 d
Steps
Wearable10,062
stable · +25 vs previous 14 d
GI burden
Companion23.8/100
worsening · +4.5 vs previous 14 d
Adherence
Companion92.4 %
stable · -3.6 vs previous 14 d
Sleep quality
Wearable73.1/100
worsening · -7.3 vs previous 14 d
Glucose, CGM daily mean
CGM126 mg/dL
stable · +0.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 61 from the failing basin, 33 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.7 next day on high-intake days · n 21
Would not help
- BR-03 Behavioural Recommendationonly 13% improved among 8 similar
- Keep simple carbs lowGI +3.1 next day on high-intake days · n 29
- Keep ultra-processed lowGI +2.9 next day on high-intake days · n 18
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.7supporter · 95%
- Simple carbohydrates+3.1detractor · 95%
- Ultra-processed food+2.9detractor · 95%
- Insoluble fibre+0.3no signal · 15%
- Dietary fat load+0.2no signal · 15%
- Caffeine-0.2no signal · 15%
- Histamine load-0.1no signal · 15%
- Alcohol0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Autonomic recovery ↓25
- WearableResting HR 75 bpm
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 2.6 · butyrate capacity 48/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 65 ms
- Sleep
- 7.6 h
- Steps
- 9,911
- Resting HR
- 77 bpm
Daily log: GI score 24, nutritional resilience 65, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02303 | 51% | S15 | GI-04 | improved | 48 |
| P-02339 | 49% | S03 | DT-01 | improved | 50 |
| P-02697 | 48% | S07 | GI-04 | improved | 56 |
| P-02235 | 47% | S14 | DT-01 | improved | 50 |
| P-02586 | 47% | S18 | DT-01 | improved | 56 |
| P-02479 | 46% | S13 | DT-01 | improved | 48 |
| P-02274 | 45% | S15 | DT-01 | improved | 50 |
| P-02484 | 45% | S15 | GI-04 | improved | 49 |
| P-02645 | 45% | S02 | HY-01 | improved | 56 |
| P-02147 | 44% | S13 | GI-04 | improved | 58 |
| P-02494 | 44% | S09 | GI-04 | improved | 47 |
| P-02538 | 44% | S02 | GI-04 | improved | 59 |